explore -WSS

explore

author：Wikipedia 2025-08-03 03:31:50 - browse：45

Sammy Kimball for STAT

Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Parkland mass shooting to be reenacted for lawsuit

focus

hotspot

WSS

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

California Joshua trees severely burned in massive wildfire

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date

Humans aren't the only ones with an imagination. Rats have it too

Prosecutors seek bail revocation for FTX founder Sam Bankman

leisure time

explore

knowledge

In Memoriam: Notable people who died in 2023

All of Us, NIH's precision medicine initiative, gets a big boost

Hollywood unions extend contract negotiations for actors

California Joshua trees severely burned in massive wildfire

Bright Health sells Medicare Advantage business to Molina

Does Medicare's free annual wellness visit do any good?

Malaria cases in Florida and Texas: Here’s what you need to know

Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date

Alkermes shareholders re

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

entertainment

Life sciences investors close nearly $6 billion in new funds

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

Brain injuries and the importance of a second opinion

Gene therapy’s promise and the high cost of hope

Medicare proceeds with plan to claw back hospital funds

Live blog: Hearing on CRISPR

focus

hotspot

entertainment

entertainment